Insulet Corporation filed a Form 8-K on September 10, 2026, disclosing that two members of its Board of Directors, Timothy J. Scannell and Michael R. Minogue, notified the company of their decisions to step down from the Board in early September 2026.

Key Highlights

  • Scannell resignation: Timothy J. Scannell stepped down from the Board effective September 3, 2026, citing health reasons.
  • Minogue resignation: Michael R. Minogue notified the company on September 8, 2026, of his intent to step down effective September 15, 2026, to focus on his candidacy for Governor of Massachusetts.
  • Scannell's tenure: According to the filing, Mr. Scannell served on the Board for 12 years, including 7 years as Chairman of the Board.
  • Minogue's tenure: The filing states Mr. Minogue served 9 years on the Board.
  • No disagreement: The filing states that neither director resigned due to any disagreement with the company on any matter relating to its operations, policies, or practices.

Insulet Board Director Departures: Reasons and Timing

Insulet Corporation (NASDAQ:PODD), a Delaware-incorporated medical device company headquartered in Acton, Massachusetts, disclosed in its September 10, 2026 Form 8-K filing that two of its Board members have stepped down within days of each other. The departures were reported under Item 5.02, covering the departure of directors or certain officers.

According to the filing, Timothy J. Scannell notified the company on September 3, 2026, of his decision to step down from the Board "for health reasons," with the departure effective that same date. The filing noted that Mr. Scannell served 12 years on the Board, including 7 years as Chairman, during which, the company stated, "he helped guide the Company through a period of significant growth and advancement."

The filing further disclosed that Michael R. Minogue notified the company on September 8, 2026, of his decision to resign effective September 15, 2026, in order "to focus on his candidacy for Governor of Massachusetts." The filing credited Mr. Minogue with 9 years of service to the company and the Board. The filing explicitly states that neither Mr. Scannell nor Mr. Minogue resigned due to any disagreement with the company on any matter relating to its operations, policies, or practices. The 8-K was signed by John W. Kapples, Senior Vice President and General Counsel.

What Was Disclosed

Insulet Corporation disclosed the Board departures of Timothy J. Scannell, effective September 3, 2026, for health reasons, and Michael R. Minogue, effective September 15, 2026, to pursue a gubernatorial candidacy, with both departures confirmed as free of any company-related disagreement.